BIRCHALL JONATHAN (Chief Commercial Officer) received a stock award from PHASEBIO PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/24/2022ACC: 0001169245-22-000075
Officer· Chief Commercial Officer
Since Nov 2021
+20K
Net shares
Net buyer
$13.6K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+20K
Price / share
$0.68
Trade value
$13.63K
% of position
New position
5/20/2022
0.00→20K
Total
Net shares
+20K
Net value
$13.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/20/2022 | A · Award | +20K | $0.68 | $13.63K | New position | 0.00 | 20K |
| Total | +20K | $13.63K | ||||||
Derivative Transactions0
No derivative transactions reported